| |
|
|
|
|
|
|
|||
|
Blood, 1 September 2007, Vol. 110, No. 5, pp. 1681-1688. Prepublished online as a Blood First Edition Paper on May 14, 2007; DOI 10.1182/blood-2006-12-060343.
Submitted December 11, 2006
Department of Pediatrics, Division of Infectious Diseases, Children's Hospital & Regional Medical Center, Seattle, WA, United States * Corresponding author; email: mboeckh{at}fhcrc.org.
The incidence of respiratory virus infection following hematopoietic cell transplantation (HCT) has likely been underestimated using conventional testing methods in symptomatic patients. This prospective study assessed viral infection episodes by testing weekly respiratory samples collected from HCT recipients, with and without symptoms reported by questionnaire, for 100 days after HCT. Samples were tested by culture and direct fluorescent antibody for respiratory syncytial virus (RSV), parainfluenza virus (PIV), and influenza A and B, and by quantitative RT-PCR for RSV, PIV, influenza A and B, and metapneumovirus (MPV). Of 122 patients, 30 (25%) had 32 infection episodes due to RSV (5), PIV (17), MPV (6), influenza (3), RSV and influenza (1). PIV, with a cumulative incidence estimate of 17.9%, was the only virus for which asymptomatic infection was detected. Lower virus copy number in patients with 0 or 1 symptom compared with 2 or more symptoms was found for all viruses in all patients (p<0.001), with PIV infection having a similar virus-specific comparison (p=0.004). Subclinical infection with PIV may help explain why infection control programs emphasizing symptoms are effective against RSV and influenza but often not against PIV.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2007 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||